PubMed:6419786 / 1608-1749 JSONTXT

Annnotations TAB JSON ListView MergeView

    GlyCosmos15-CL

    {"project":"GlyCosmos15-CL","denotations":[{"id":"T14","span":{"begin":77,"end":79},"obj":"Cell"}],"attributes":[{"id":"A14","pred":"cl_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CL:0004120"}],"text":"Suppression of endogenous TSH by thyroxine treatment depresses prostaglandin I2 contents and augments prostaglandin E2 and F2 alpha contents."}

    GlyCosmos15-Sentences

    {"project":"GlyCosmos15-Sentences","blocks":[{"id":"T10","span":{"begin":0,"end":141},"obj":"Sentence"}],"text":"Suppression of endogenous TSH by thyroxine treatment depresses prostaglandin I2 contents and augments prostaglandin E2 and F2 alpha contents."}

    CL-cell

    {"project":"CL-cell","denotations":[{"id":"T14","span":{"begin":77,"end":79},"obj":"Cell"}],"attributes":[{"id":"A14","pred":"cl_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/CL:0004120"}],"text":"Suppression of endogenous TSH by thyroxine treatment depresses prostaglandin I2 contents and augments prostaglandin E2 and F2 alpha contents."}